A White House spokesperson, Kush Desai, referred Donald Trump's status to the Department of Health & Human Services after the FDA program was utilized for potential patient access.
6 reports, 2 independent
Updated Sep 21
Gone quiet
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A White House spokesperson, Kush Desai, referred Donald Trump's status to the Department of Health & Human Services after the FDA program was utilized for potential patient access.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- White House
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
Department of Health & Human Services
government department in the state of Victoria, Australia
- The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.
- The Trump administration plans to dismantle the Office for Civil Rights and shift its civil rights enforcement duties to the Justice Department.
Related events
- Jonathan Reiner appeared on CNN as a medical analyst to critique the official health narrative regarding Donald Trump.
- Trump administration slashes food safety enforcement and reduces workforce at FDA, FSIS, and CDC.
- The administration is planning a major overhaul of the Head Start program, utilizing officials from the Department of Health & Human Services.